Introduction
For more than a decade, gene therapy has been extensively studied in animal models of human disease, as well as in numerous clinical trials. Human studies in particular, however, are hampered by the lack of noninvasive methods to evaluate the magnitude, distribution, and timing of transgene expression. Several reporter genes 1, 2 can facilitate the study of such issues in animal experiments, but the strategies for monitoring reporter genes, in general, require invasive tissue biopsy samples, often performed after euthanasia. Alternative approaches that allow in vivo transgene imaging must be identified for clinical studies.
Recent advances in imaging technologies have now made it possible to noninvasively visualize reporter gene expression in vivo. Noninvasive real-time analysis of gene expression is possible using reporter genes with optical signatures (eg green fluorescent protein (gfp), 1 firefly luciferase, 3 and Renilla luciferase 4 ). However, spatial resolution is poor, and their use at present is limited to small animals. Furthermore, signal attenuation in deep tissue and signal dependence on regional hemoglobin concentration make this approach less than ideal for studies exploring the spatial distribution of transgene expression within the lungs. Positron-emitting radioisotope-based technologies, however, are an attractive alternative, because of the high sensitivity of associated methods, photon attenuation correction (which makes accurate tissue quantitation possible), and the development of small animal positron emission tomography (PET) scanners (which allows animal methods to be developed for direct translation into clinical investigations). 5 Accordingly, several experimental studies have shown that PET can be used to quantify gene expression by measuring the accumulation of radiolabeled tracers which are trapped only in tissues expressing reporter proteins such as the Herpes simplex virus type-1 thymidine kinase (HSV1-TK) in vivo. 6, 7 Several mutant HSV1-TK enzymes (mHSV1-TK) have been developed to further improve the sensitivity of PET imaging to detect and quantify the cellular accumulation of radioactive tracers. 7, 8 To date, the validity of this strategy to quantify mHSV1-tk reporter gene expression has been demonstrated in the liver, 9 in tumor xenografts in rodents, 10 and in myocardium; 11 recently, we have confirmed these results in rat lungs. 12 The advantages of using PET to repeatedly image transgene expression has been emphasized repeatedly. 9, 13 However, no study has yet taken advantage of the potential of PET imaging to monitor the spatial (intraorgan) distribution of transgene expression. This issue is particularly important when considering gene therapy for parenchymal lung diseases such as pneumonia or acute respiratory failure, where the optimal means of vector delivery to the distal airspaces of the lungs remains to be determined. For instance, while the direct instillation of vector results in a heterogeneous deposition within limited portions of the lungs, 14 inhalation of aerosolized vector solutions can result in more diffuse transgene distribution throughout the lungs. However, aerosolization is relatively inefficient, since only 10-30% of aerosolized particles reach the lower airways.
Several techniques have been proposed to increase transgene expression following direct airway instillation of vectors (eg exogenous surfactant, perfluorochemical liquids), but their impact on vector spatial distribution remains unclear. 15 Cationic lipid-based gene delivery has been proposed in combination with plasmid DNA 16 or adenoviral vectors. 17 In these cases, the transgenes are mainly expressed in pulmonary endothelial cells. 17 In contrast, to deliver transgenes to airway or alveolar epithelial cells, vectors are usually administered intratracheally. In these cases, surfactant has been proposed as a method to improve adenovector delivery based on its biophysical properties, which should result in a more rapid distal dispersion of vector than with saline. Furthermore, surfactant reuptake by alveolar type 2 epithelial cells as part of normal surfactant metabolism raises the possibility that adenovectors in surfactant may be cotransported into these cells, providing a mechanism to hypothetically improve gene transfer efficiency to these tissues. 15 The current study, then, was designed to test PET as a means of comparing two different vector delivery vehicles (specifically using surfactant versus saline as the vehicle for vector delivery) on the spatial distribution of adenovirus-based reporter gene transfer within rat lungs. The results demonstrate the power of this imaging technology to generate useful and meaningful information about the effectiveness of different delivery strategies.
Results
The total number of imaging pixels sampled with PET during image analysis was not statistically different between the surfactant and the saline groups (1872 versus 1974 pixels/g of body weight, respectively) (mean weight7SD¼296740 g). Thus, comparable volumes of lung tissue were analyzed between the two groups.
The ventral-to-dorsal distribution of [
18 F]-FHBG within the lungs was not different between the two experimental groups ( Figures 1, 2) ; in both groups, tracer concentration (presumably reflecting greater reporter gene expression) was greater in the intermediate and dorsal parts of the lungs than in the ventral portions (Figure 2) , probably reflecting the effects of intratracheal administration on the distribution of vector.
In contrast, a statistically significant difference in the lateral-to-medial distribution of [ 18 F]-FHBG was detected between the two groups ( Figures 3, 4) . While in both groups, tracer concentration was greatest in the intermediate portions of the lungs, tracer concentration was greater in the lateral regions of the surfactant group than in the saline group (Figure 4) Figure 1 . To normalize for differences in tracer concentration between animals, the regional radioactivity values in each pixel were expressed as a fraction of the total radioactivity of its corresponding whole-lung ROI. The normalized values were summed in each region, and the resulting value corresponds to the fraction of total radioactivity of the whole-lung ROI originating from that particular region. Bars are standard deviations. Figure 6 also shows that o5% of all pixels analyzed in images of the saline group had values greater than 0.3% ID/ml. In the surfactant group, however, 23% of all analyzed pixels had values 40.3%ID/ml.
To identify the regional location of pixels with tracer concentration greater than this threshold (0.3% ID/ml) in the surfactant group, we created parametric images in which all pixels with values greater than 0.3% ID/ml were coded red, and those with values less than 0.3% ID/ml were coded blue. As seen in Figure 7 , pixels with high radioactivity values (40.3% [ 18 F]-FHBG ID/ ml) were seen on all slices, and were evenly distributed throughout each slice in animals of the surfactant group. 
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In other words, the increased efficiency of gene transfer in the surfactant group was not confined to any single topographic region within the lungs. Differences in right versus left lung tracer distribution were studied by pooling the regions -of interest (ROIs) as a function of their lateral position in the thorax. Therefore, the 'left' lung (ie ROIs on the left side of the PET images) represents both the left lung and the accessory lobe of the right lung, which, in vivo, is situated in the left hemithorax. There was no difference between tracer concentration in the right and the 'left' lung (right/left ratio¼0.9870.05 in the surfactant group and 0.9870.13 in the saline group). Overall, the amount of tracer taken up by the lungs (sum of radioactivity measurement in all PET slices) was greater in the right lung (0.5270.16% ID) than in the 'left' lung (0.4170.10% ID, Pp0.05) (Figure 8 ). The ratio of uptake in the right versus 'left' lung (1.2770.25) mainly reflects differences in lung weight between the right and 'left' lung (right/left lung weight ratio¼1.1570.10, where 'left' lung includes the right lung accessory lobe).
Discussion
This study is the first to demonstrate the usefulness of PET imaging to evaluate the spatial distribution of reporter gene expression within an organ, in this case, specifically the lungs. Furthermore, it demonstrates the superiority of surfactant-based over saline-based vehicles in terms of overall gene transfer efficiency, spatial homogeneity, and peripheral distribution within the lungs.
Methodological issues
Noninvasive quantitation of regional transgene expression within the lungs would be highly desirable to refine and optimize gene therapy delivery systems for use in human lung diseases. One strategy to accomplish this goal would be to directly image gene delivery using a radiolabeled vector, 18, 19 but this approach would require radiolabeling of the vector genome and might not provide information about transgene function. Labeling of vector capsids is not likely to be helpful, due to the rapidity by which these proteins are removed and degraded in human cells. Moreover, the mere visualization of exogenous DNA accumulation at any one site might not correlate with expression levels of the therapeutic gene product. 20 An alternative strategy incorporates reporter genes that can be used to monitor gene expression and function. While monitoring reporter gene expression has traditionally required tissue biopsy samples, or direct (invasive) fluorescent imaging of proximal airways, the emergence of new imaging technologies now allows in vivo reporter gene expression to be visualized noninvasively. However, methods based on bioluminescence 2 or magnetic resonance imaging (MRI) 21 are not well suited for transgene expression imaging within the Imaging vector delivery to the lungs J-C Richard et al lungs because of signal attenuation in tissue (bioluminescence methods) or low proton density in the lungs (MRI). In contrast, radiotracer imaging methods are highly sensitive 20 and isotropic, features which are especially attractive for lung imaging.
The HSV1-tk PET reporter system used in this study has been extensively studied 7, 10, [22] [23] [24] and several mHSV1-TK enzymes have been developed to improve the sensitivity of PET imaging. We have recently demonstrated the validity of this strategy in the lungs of normal rats using mNLS-HSV1sr39tk as a PET 22, 23 In addition to being able to quantify the overall reporter gene expression noninvasively, one of the most exciting features of PET imaging is its potential to evaluate the spatial distribution of gene transfer within the lungs. However, lung boundaries are not easily detected on PET images without an attenuation scan (allowing the chest wall to be defined by creating a regional map of tissue density). Unfortunately, attenuation images of sufficient quality are not yet readily available with the current generation of microPET devices. Therefore, in this study, ROIs were drawn on tomographic chest slices with radioactivity greater than the background. The result is that low activity pixels at the periphery of the lung may have been excluded from the analysis. Even so, the number of pixels sampled with PET for image analysis was not statistically different between the surfactant and saline groups. Therefore, any error involving pixel dropout was systematically present, and would not explain the measured differences in the spatial distribution of gene expression between the two groups.
A related problem is due to the influence of the so-called partial-volume averaging on estimates of lung radioactivity with PET. Given the relatively limited spatial resolution of PET, the activity measurements in picture elements representing regions within the lungs can be influenced by nearby low-activity regions (eg outside the thorax). The result will be an underestimation of signal intensity/distribution. We have previously shown that for whole-lung ROIs, [ 18 F]-FHBG radioactivity measurements in rats were strongly and linearly correlated to direct measurements of tissue radioactivity obtained with a gamma counter. 12 A major reason for this strong correlation is that since we administer the viral vector intratracheally, the lung is the only organ to express the viral kinase, and therefore the only tissue to retain high levels of [ 18 F]-FHBG. However, for smaller ROIs, say at the periphery of the lung, some partialvolume averaging effect must be present. In addition, respiratory variation due to tidal breathing might produce a similar effect. Even so, these effects would be equally present for both experimental groups. Thus, Figure 1 ), or at the periphery of the lung (Figure 3) , it would not explain the measured differences between groups (Figure 4) .
Comparison of vehicles
Surfactant-based vehicles have been reported to allow more efficient adenovirus-mediated gene transfer, and to facilitate vector dispersion in the lungs. 15, [25] [26] [27] However, the experimental evidence supporting this perception is without strong scientific support. Whereas an increase in gene transfer efficiency may be obtained with surfactantbased vehicles when a low volume of delivery medium is used, 27 the superiority of surfactant over saline-based vehicles was not found at higher delivery volumes (4 ml/kg of b.w.). 27 In addition, numerous other factors may interfere with the efficiency of vehicle delivery (eg lung instillation technique, surfactant concentration in the vehicle, etc). Using a method of vector delivery similar to the one employed in the present study, Weiss et al 15 reported a nonstatistically significant trend for superiority of surfactant-based delivery of viral vector compared to saline. The statistically positive results in the present study may simply reflect the sensitivity of PET imaging, as well as its ability to assess reporter gene expression over the entire lung, reducing variation that contributes to imprecision with other biological techniques in which only samples of the lungs are analyzed.
Likewise, the benefit of surfactant on vector dispersion within the lungs has not been consistently identified 15, 25 -again possibly reflecting a lack of power of measurement methods in such studies. Theoretically, the surface active properties of surfactant should lead to rapid dispersion and deposition of vector into the alveolar spaces; saline, on the other hand, is rapidly absorbed from the airway mucosa, possibly limiting its spread to the distal airways and alveolar spaces. 27 In our study, a slightly increased tracer concentration in the peripheral regions of the lungs in the surfactant group was consistently observed compared with tracer concentration in similar regions of the lungs of rats in the saline group. Although the magnitude of this redistribution is low and its biological signification may not be great, it demonstrates that biologically significant differences (say in future studies) should be easily detected by PET imaging.
Clinical implications
Optimal vector delivery is a critical issue in developing gene therapy protocols for lung diseases in humans. To date, a noninvasive method that would allow both the level and spatial distribution of reporter transgene expression to be evaluated is lacking. The PET reporter system described in this study should be viewed as a 'first-generation' system, one that will undoubtedly improve as alternative reporter genes, probes, and PET instruments are developed and evaluated. Nevertheless, the potential value of such a system in both experimental and clinical studies is obvious. Our results demonstrate that PET imaging should be a useful new tool to evaluate methods of Imaging vector delivery to the lungs J-C Richard et al vector delivery to the lungs noninvasively, which can be applied to humans in the near future.
Material and methods

Shuttle vector and adenovirus construction
Replication-deficient (E1a/E3 deleted) recombinant human type 5 adenoviruses encoding for a mutant Herpes simplex virus type-1 thymidine kinase (mNLSHSV1sr39tk) 7 and an enhanced green fluorescent protein (Ad-CMV-mNLS-HSV1sr39tk-egfp) were constructed as described elsewhere. 12 This mutant Herpes simplex virus type-1 thymidine kinase was specifically engineered with a mutation in its nuclear localization sequence (mNLS) to improve enzyme expression in the cytoplasm and enzyme efficiency to phosphorylate acycloguanosine derivatives. 7 
Experimental protocol
The present study was approved by the Washington University School of Medicine's Animal Studies Committee, and performed on 17 Sprague-Dawley rats (mean weight7SD¼296740 g), assigned to two experimental groups: a group in which the rats were infected with 5 Â 10 10 viral particles of Ad-CMV-mNLS-HSV1sr39tk-egfp using a surfactant-based method ('surfactant group', n¼8 animals) and another group in which the rats were infected with an identical viral dose using a saline-based method ('saline group', n¼9 animals) (see below).
Adenovirus delivery to rat lungs
Rats were anesthetized intraperitoneally with 90 mg/kg of ketamine and 9 mg/kg of xylazine. They were then orally intubated with a 16-gauge angiocatheter (SUR-FLO s Teflon IV Catheter, TERUMO, Somerset, NJ, USA). While the animals were spontaneously breathing and immediately prior to instillation of vehicle, forced exhalation was achieved by circumferential compression of the thorax. The animals of the 'Surfactant group' then received 200 ml of a mixture of adenovirus in a 50% surfactant (Survanta s , Abbot laboratories, Columbus, OH, USA)-50% phosphate-buffered saline vehicle, 12, 28, 29 while animals of the 'saline group' received 200 ml of a mixture of adenovirus and phosphate-buffered saline vehicle. Adenovirus delivery to rat lungs was immediately followed by an instillation of 500 ml of air. Compression was then discontinued after endotracheal instillation, resulting in a forceful inspiration that facilitated adenoviral dispersion to the distal airspaces. Rats were rotated 901 after each instillation, and the procedure was repeated four times with 5-min intervals between instillations. Rats were then allowed to recover prior to extubation.
PET study [ 18 F]-FHBG was synthesized as described elsewhere. 30 PET imaging was performed on a microPET-R4 camera (Concorde MicroSystem Inc., Knoxville, TN, USA), 31, 32 which has a field-of view of 8 cm axially by 11 cm transaxially, and a spatial resolution of 2.3 mm. Images were generated by two-dimensional filtered-back projection from three-dimensional sinogram data, as previously described. 33 The voxel size after reconstruction was 0.87 mm 3 .
Rats were anesthetized with isoflurane shortly before injection of tracer. Tracer dose was measured on a dose calibrator regularly crosscalibrated with the microPET device, and a bolus of 1.170.7 mCi/g (41726 kBq/g) of [
18 F]-FHBG was injected intravenously into the tail vein. After 1 h (to allow for clearance from blood, reducing background radiation), each animal was placed in the supine position into the microPET scanner, with image acquisition for a period of 15 min.
Image analysis
ROI were drawn on the left and right lungs. Version 4.0 of the program Analyze s was used for image analysis. 34 All radioactivity measurements (injected dose, PET images) were decay corrected to the same time point (beginning of the PET scan) and mean activity values per ml of lung for each ROI were normalized to the injected dose (ID) of [ 
Data analysis
To quantify lung transgene expression heterogeneity, radioactivity values of all the ROIs were obtained on a pixel-by-pixel basis, and the coefficient of variation was computed by the ratio of their standard deviation to their mean value.
To represent the spatial distribution of transgene expression along the ventral-orsal axis, a pixel-binning method was used as previously described. 35, 36 Briefly, the x-and y-coordinates for each picture element (pixel), along with their respective radioactivity values, were recorded for each ROI (after exclusion of ROI containing less than 100 pixels). To normalize for differences in tracer concentration between animals, the regional radioactivity values in each pixel were expressed as a fraction of the total radioactivity of their corresponding ROI. The pixel data were then sorted, first by their y-coordinate. Next, within each value for y, the data were sorted again by their x-coordinate. The result was a listing of the pixels by location, beginning in the most ventral-to-medial portion of the region and ending with the most dorsal-to-lateral portion of the region. Each region contained 179715 pixels. Arbitrarily, the data were divided into 20 bins that were stacked vertically in the ventral-to-dorsal direction; so each bin contained approximately 9 pixels, whose normalized radioactivity could then be summed. The resulting value for each bin corresponds to the fraction of total radioactivity of the ROI originating from that particular bin (the sum of all bins' fractional radioactivity equals 100%). Each bin's normalized activity values were then averaged across animals of the same experimental group.
An identical procedure was performed to express the spatial distribution of transgene expression along the lateral-to-medial axis. This method of pixel sorting and binning is a descriptive method of signal distribution within the lungs. We estimate that the bins in our various image analyses were approximately 5-9 mm in diameter. Previous work by us and others 12, 37 have shown strong linear correlations between PET estimates of radioactivity and external gamma counting on regions at least as small as 10 mm diameter.
Statistical analysis
Comparisons between the two experimental groups were performed by the t-test. Comparisons among lung 
